Similar articles for PMID: 24144450

Year	Number of Results
2009	2
2010	2
2011	4
2012	11
2013	18
2014	26
2015	50
2016	40
2017	50
2018	32
2019	45
2020	49
2021	59
2022	49
2023	18
2024	0

1

Intravitreal aflibercept for treatment-resistant neovascular age-related macular degeneration.

Chang AA, Li H, Broadhead GK, Hong T, Schlub TE, Wijeyakumar W, Zhu M. Chang AA, et al. Ophthalmology. 2014 Jan;121(1):188-192. doi: 10.1016/j.ophtha.2013.08.035. Epub 2013 Oct 18. Ophthalmology. 2014. PMID: 24144450 Clinical Trial.

2

Intravitreal Aflibercept for Treatment-Resistant Neovascular Age-Related Macular Degeneration: 12-Month Safety and Efficacy Outcomes.

Chang AA, Broadhead GK, Hong T, Joachim N, Syed A, Schlub TE, Toth L, Peto T, Zhu M. Chang AA, et al. Ophthalmic Res. 2015;55(2):84-90. doi: 10.1159/000440886. Epub 2015 Dec 5. Ophthalmic Res. 2015. PMID: 26637166 Clinical Trial.

3

Intravitreal aflibercept injection for neovascular age-related macular degeneration: ninety-six-week results of the VIEW studies.

Schmidt-Erfurth U, Kaiser PK, Korobelnik JF, Brown DM, Chong V, Nguyen QD, Ho AC, Ogura Y, Simader C, Jaffe GJ, Slakter JS, Yancopoulos GD, Stahl N, Vitti R, Berliner AJ, Soo Y, Anderesi M, Sowade O, Zeitz O, Norenberg C, Sandbrink R, Heier JS. Schmidt-Erfurth U, et al. Ophthalmology. 2014 Jan;121(1):193-201. doi: 10.1016/j.ophtha.2013.08.011. Epub 2013 Sep 29. Ophthalmology. 2014. PMID: 24084500 Clinical Trial.

4

Brolucizumab Versus Aflibercept in Participants with Neovascular Age-Related Macular Degeneration: A Randomized Trial.

Dugel PU, Jaffe GJ, Sallstig P, Warburton J, Weichselberger A, Wieland M, Singerman L. Dugel PU, et al. Ophthalmology. 2017 Sep;124(9):1296-1304. doi: 10.1016/j.ophtha.2017.03.057. Epub 2017 May 24. Ophthalmology. 2017. PMID: 28551167 Clinical Trial.

5

Intravitreal Aflibercept for Neovascular AMD: Short-Term Clinical Effects of Intravitreal Aflibercept Injection as a Predictor of Long-Term Results.

Liu EM, Shah G, Blinder KJ, Smith BT, Thomas MA. Liu EM, et al. Ophthalmic Surg Lasers Imaging Retina. 2015 Nov-Dec;46(10):1021-7. doi: 10.3928/23258160-20151027-06. Ophthalmic Surg Lasers Imaging Retina. 2015. PMID: 26599244 Clinical Trial.

6

Short-term results of switchback from aflibercept to ranibizumab in neovascular age-related macular degeneration in clinical practice.

Despreaux R, Cohen SY, Semoun O, Zambrowski O, Jung C, Oubraham H, Souied EH. Despreaux R, et al. Graefes Arch Clin Exp Ophthalmol. 2016 Apr;254(4):639-44. doi: 10.1007/s00417-015-3084-1. Epub 2015 Jun 20. Graefes Arch Clin Exp Ophthalmol. 2016. PMID: 26092633

7

Aflibercept treatment for patients with exudative age-related macular degeneration who were incomplete responders to multiple ranibizumab injections (TURF trial).

Wykoff CC, Brown DM, Maldonado ME, Croft DE. Wykoff CC, et al. Br J Ophthalmol. 2014 Jul;98(7):951-5. doi: 10.1136/bjophthalmol-2013-304736. Epub 2014 Feb 11. Br J Ophthalmol. 2014. PMID: 24518078 Free PMC article. Clinical Trial.

8

Intravitreal aflibercept for submacular hemorrhage secondary to neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.

Kim JH, Kim CG, Lee DW, Yoo SJ, Lew YJ, Cho HJ, Kim JY, Lee SH, Kim JW. Kim JH, et al. Graefes Arch Clin Exp Ophthalmol. 2020 Jan;258(1):107-116. doi: 10.1007/s00417-019-04474-0. Epub 2019 Nov 18. Graefes Arch Clin Exp Ophthalmol. 2020. PMID: 31741044 Clinical Trial.

9

Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration.

Heier JS, Brown DM, Chong V, Korobelnik JF, Kaiser PK, Nguyen QD, Kirchhof B, Ho A, Ogura Y, Yancopoulos GD, Stahl N, Vitti R, Berliner AJ, Soo Y, Anderesi M, Groetzbach G, Sommerauer B, Sandbrink R, Simader C, Schmidt-Erfurth U; VIEW 1 and VIEW 2 Study Groups. Heier JS, et al. Ophthalmology. 2012 Dec;119(12):2537-48. doi: 10.1016/j.ophtha.2012.09.006. Epub 2012 Oct 17. Ophthalmology. 2012. PMID: 23084240 Clinical Trial.

10

Zhu M, Wijeyakumar W, Syed AR, Joachim N, Hong T, Broadhead GK, Li H, Luo K, Chang A. Zhu M, et al. Graefes Arch Clin Exp Ophthalmol. 2017 Mar;255(3):475-484. doi: 10.1007/s00417-016-3477-9. Epub 2016 Aug 30. Graefes Arch Clin Exp Ophthalmol. 2017. PMID: 27572301 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

354 results

Results by year